PATENT CLAIM ANALYSIS

Application Number: 16084927
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "019300"]

Abstract:
The peptides of the invention are of formula (I) or (IV). The peptides of the invention are useful in the treatment of cancer.

Claim (Index 48):
The peptide or pharmaceutical salt thereof of any of the previous  claims 1 - 47 , or alternatively,\n a peptide comprising the sequence SEQ ID NO: 12: Ala-Pro-Lys-Val-Val-Ile-Leu-Lys-Lys-Ala-Thr-Ala- Tyr-Ile or a variant thereof having at least a 85% of identity with SEQ ID NO: 12, or a pharmaceutical salt thereof,\n which is conjugated to a label.

Metadata:
- Claim Count in Document: 69.0
- Percentile: 97.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13984762', '14776668', '13397195', '11290735', '15581749']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.732720390884165
- 35 USC 102 Novelty (BERT): 0.5156585992356407
- Combined Prediction Score: 0.7110142117193126
- Mean Citation Score: 260.430318
- Max Citation Score: 267.25793
- Similarity Product: 178.85365910277665

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test